Ovid seeks metamorphosis into public company with $86M IPO

This follows on from a fairly quiet start to the year in terms of public offerings from biotech, although just this week Biohaven Pharmaceutical filed to raise up to $100 million in its IPO attempt to … Ovid help out on the Osaka-based company’s …
( read original story …)


Related Post

Japan’s Bank Lending 2.6% vs. 2.4% forecast
views 169
Investing.com - Japan’s bank lending rose un...
Shionogi Inc. President and CEO John Keller to Rec...
views 182
Shionogi Inc. is the US subsidiary of Shionogi & C...
Changing tastes brew bitter times for Japan’...
views 159
TOKYO — From beer gardens on the rooftops of depar...
Japan central bank keeps policy intact, cuts price...
views 122
TOKYO — The Bank of Japan has wrapped up a policy ...
Prosecutors to question ex-chief of scandal-hit Mo...
views 133
The special investigative unit of the Osaka Distri...
Tokyo 2020 Olympics could deploy facial recognitio...
views 126
Now the organizing committee of the Tokyo 2020 Oly...
The clash between China and Japan could get much m...
views 139
China and Japan have both become ascendant powers ...
UK Sport rejects Tokyo 2020 funding appeals from s...
views 190
We are operating in a tight financial envelope, an...
Manitoba picks four groups to run pot shops in pro...
views 116
while MedReleaf takes smaller strides Sun Life Fin...
Sapporo City
views 168
Sapporo is the largest city in the northernmost ma...